Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02726763 · ClinicalTrials.gov registry record · NA
Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training
A NA study of Breast Cancer Survivors, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT02726763: Active NA study of Breast Cancer Survivors, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02726763 is a NA study of Breast Cancer Survivors that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 18 participants, below the 2,759-participant average among 8 other Breast Cancer Survivors trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02726763, a NA study of Breast Cancer Survivors, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, the investigators are testing transcranial direct current stimulation (tDCS) in breast cancer survivors. In this pilot study, the investigators want to learn if it is feasible to use this device in memory rehabilitation.
Primary Outcome
feasibility defined by the number of subjects recruited in a six month time frame
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- DEVICE Transcranial Direct Current Stimulation (tDCS)
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2016-03-30 |
| Est. Completion | 2026-03 |
| Phase | NA |
What the registry record for NCT02726763 still lists
NCT02726763 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 2,759-participant average among 8 other Breast Cancer Survivors trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Breast Cancer Survivors appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.
NCT02726763 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02726763 about?
NCT02726763 is a clinical study titled "Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training". In this study, the investigators are testing transcranial direct current stimulation (tDCS) in breast cancer survivors. In this pilot study, the investigators want to learn if it is feasible to use this device in memory rehabilitation.
What is the current status of trial NCT02726763?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2016-03-30. Estimated completion is 2026-03.
What conditions does trial NCT02726763 study?
This clinical trial studies the following conditions: Breast Cancer Survivors.
What interventions are being tested in trial NCT02726763?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Transcranial Direct Current Stimulation (tDCS) (DEVICE).
Who is sponsoring clinical trial NCT02726763?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02726763 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Survivors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02726763's enrollment target sits among peer trials
18 9th of 8 the lowest of 8 other Breast Cancer Survivors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer Survivors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rowing Following Breast Cancer Chemotherapy
RECRUITING · NA
-
Improving Cognition After Cancer
ACTIVE NOT RECRUITING · NA
-
Physical Activity Promotion for Breast and Endometrial Cancer Survivors
COMPLETED · NA
-
UCF MammoChat: Image Repository
RECRUITING
-
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)
RECRUITING
-
Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI